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Congenital pulmonary airway malformation (CPAM) is a developmental malformation of the lower respiratory tract. 
We report the case of a male newborn diagnosed with cystic lung disease during prenatal ultrasound. A cesarean section 
was performed at the 32nd gestational week because of premature rupture of the membranes, and soon after the 
delivery the newborn developed respiratory failure and died. The aim of this study is to report an autopsy case because 
of its rarity, and to briefly discuss the CPAM subtypes and differential diagnosis of cystic lung diseases of childhood. 
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CASE REPORT
A 27-year-old Gravida 4, Para 3, Abortus 0 patient 
was admitted to the obstetrics ward of a referral 
hospital at the 32nd gestational week, with the 
diagnosis of premature rupture of the membranes 
and fetal malformations. The prenatal care was 
initiated during the second month, and serological 
tests for toxoplasmosis, rubella, syphilis, and human 
immunodeficiency virus were negative. The fetal 
ultrasonography at 29 weeks’ gestation showed 
reduced left thoracic size and a large cystic mass 
occupying the right hemithorax. A cesarean section 
was performed for fetal distress, and a male newborn 
was delivered weighing 2030 g. The baby presented 
cardiorespiratory arrest immediately after birth and 
death was certified at 37 minutes of life. Consent for 
autopsy was granted by the parents.
AUTOPSY FINDINGS
On opening the chest, a mediastinal shift to 
the left hemithorax was noted. The heart and lungs 
together weighed 38 grams. The right lung measured 
9 cm × 7 cm × 3 cm and showed a hyperinflated 
aspect exhibiting multiple cystic formations with up 
to 7 cm in diameter (Figure 1). The left lung measured 
4 cm × 2cm × 1 cm and appeared immature. The heart 
had normal anatomical connection with the large 
arteries, but on opening, a 2 mm atrial septal defect 
was evident. No other systemic malformation was 
present.
The thoracic organs were fixed in formalin for 
subsequent dissection (Figure 2A). The right lung cut 
surface showed to be markedly altered by the presence 
of numerous contiguous cystic formations outlined 
by thin walls, imparting a honeycomb appearance. 
It additionally showed two lobes, both affected by 
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the malformation. The left lung had two lobes and 
appeared compact (Figure 2B).
Histological examination of the right lung stained 
with hematoxylin-eosin (H&E) and Periodic Acid Schiff 
(PAS) revealed a proliferation of the terminal respiratory 
structures forming cysts that were lined with ciliated 
pseudostratified epithelium with polypoid projections 
of the mucosa, small cartilage foci in the wall of the 
bronchial structures (Figure 3A, 3B), clusters of goblet 
cells, and mucinous glands (Figure 4A and 4B). The left 
lung showed an immature parenchyma with the 
predominance of collapsed alveoli. However, cartilage 
around the bronchi was present.
There were no signif icant changes in the 
vascularization of both lungs. The placenta did not 
present abnormalities on histological examination.
DISCUSSION
The incidence of congenital lung malformations 
ranges from 30 to 42 cases per 100,000 inhabitants 
per year, and cystic diseases account for 25%-30% 
of this total.1
Congenital pulmonary airway malformations 
(CPAMs) are a heterogeneous group of cystic and 
non-cystic lung lesions that result from early airway 
maldevelopment with the incidence ranging between 
1:10,000 and 1:35,000 newborns.2-6 This entity was 
first classified by Ch’in and Tang7 in 1949 as congenital 
cystic adenomatoid malformation (CCAM). Although 
originally described as “congenital cystic adenomatoid 
Figure 1. Gross view of the hyperinflated right lung 
with multiple cysts.
Figure 2. A – Front view of the thoracic organs after formalin fixation; B – Posterior view of the thoracic organs. 
Note the right lung with numerous contiguous cystic formations outlined by thin walls with honeycomb appearance 
(arrow) and the immature left lung with the two lobes (arrowhead).
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malformation,” this entity now has the designation of 
“congenital pulmonary airway malformation” because 
the lesions described as “cystic” were present in only 
three of the five subtypes and “adenomatoid” in only 
one subtype.6
The accepted pathogenesis for CPAM is that an 
abnormal airway patterning and branching during 
lung morphogenesis results in the appearance of lung 
cysts.5 It is considered a hamartomatous abnormality 
of the bronchial tree by some authors, whereas others 
Figure 4. A – Photomicrograph of the right lung revealing clusters of mucinous glands (PAS, 200X); and B – Presence 
of the goblet cells (PAS, 400X).
Figure 3. Photomicrograph of the right lung revealing in A – Cystic dilated bronchiolar structures (H&E, 200X); and 
B – Polypoid projections of the mucosa and rare cartilage foci in the bronchial wall (H&E, 200X).
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favor the etiology of an arrest in the development 
of the fetal bronchial tree with airway obstruction.8 
Although the exact cellular mechanisms involved in 
the pathogenesis are unknown, many potential genes 
have been associated with the formation of lung cysts.5
In 1977, CPAM was class if ied into three 
types (I, II, and III) by Stocker et al.9 This classification 
is based on clinical, macroscopic, and microscopic 
criteria. The microscopic features that distinguish 
CPAM from normal lung include: (i) proliferation 
of the terminal respiratory structures forming cysts; 
(ii) polypoid projections of the mucosa; (iii) increased 
smooth muscle and elastic tissue within cyst walls; 
(iv) the absence of cartilage; (v) the presence of 
mucous-secreting cells; and (vi) the absence of 
inflammation.5 In 2009, two subtypes were added to 
Stocker et al.’s classification, namely: type 0, which 
corresponds to the proximal bronchial anomaly (acinar 
dysplasia); and type IV, which corresponds to the 
peripheral lung anomaly.2,10 Each of the subtypes has 
characteristics that favor the classification:
Type 0: 1%-3% of frequency, birth presentation, 
small cysts of 0.5 cm with ciliated pseudostratified 
epithelial lining and goblet cells, bronchiolar cartilage 
present, and all lobes involved.4
Type I: 60%-65% of frequency, newborn 
respiratory distress, multiple large cysts with 10 cm or a 
single dominant cyst, ciliated pseudostratified epithelial 
lining with bronchiolar differentiation, mucinous cells 
in 33% and cartilage present in 10% of cases, and 
only one lobe involved.4,9
Type II: 10%-15% of frequency, first month of 
life presentation, multiple spaced cysts with 2.5 cm 
(sponge-like appearance), ciliated cuboidal or columnar 
epithelial lining, the absence of mucinous cells and 
cartilage, and the involvement of usually only one 
lobe.4,9
Type III: 8% of frequency, in uterus or birth 
respiratory distress, bulky firm mass with adenomatoid 
appearance and cysts of 1.5 cm size, ciliated cuboidal 
epithelial lining, the absence of mucous cells and 
cartilage, and the involvement of usually only one lobe 
or one lung.4,9
Type IV: 10%-15% of frequency, newborn 
respiratory distress, pneumothorax, pneumonia or 
incidental finding, peripheral cysts with acinar-alveolar 
epithelial differentiation, a 7-cm-sized cyst and 
flattened alveolar lining cells, the rare absence of 
mucous cells and cartilage, and usually only one lobe 
involved.4
The diagnosis of type I CPAM, in this case, 
was based on clinical presentation and macroscopic 
finding characterized by multiple large cysts, which 
was confirmed by histological examination, and which 
demonstrated cysts with ciliated pseudostratified 
epithelial lining with bronchiolar differentiation, a 
cluster of goblet cells, mucinous glands, and small 
cartilage foci. The risk of respiratory distress at birth 
is up to 30% in cases of type I CPAM.1
The symptoms and prognosis depend on the 
degree of pulmonary involvement.3-5,8 The clinical 
presentation spectrum varies from asymptomatic cases, 
recurrent pneumonia, or respiratory insufficiency.2 
In severe cases, patients develop respiratory failure 
even in the neonatal period, but others have a benign 
clinical course, with the manifestation of chronic 
obstructive pulmonary disease or recurrent pneumonia 
as an adult.3-5,8 In our case, the lung malformation 
was responsible for the early acute respiratory failure 
and death.
In a literature review on multi-cystic congenital 
lung diseases, the main differential diagnoses of 
CPAM should include congenital lobar over-inflation 
(CLO),1,11,12 primary ciliary dyskinesia (PCD),13,14 cystic 
fibrosis (CF),15 pulmonary sequestration (PS),1 and 
Williams–Campbell syndrome (WCS).16,17
CLO is a rare lung malformation, which is also 
referred to as congenital lobar emphysema with a 
frequency between 1:20,000 and 1:30,000 births. 
It is characterized by the hyperinflation of a lung 
lobe by air trapping.1,11,12 This condition can also 
evolve with acute respiratory failure at birth, similar 
to our case. The pulmonary histopathology of CLO is 
usually normal, with mild alveolar dilatation without 
destruction of the alveolar septa,11 which was not 
observed in our case.
Another hypothesis, based on the newborn’s 
outcome, is PCD, which is also rare with an estimated 
incidence between 1:10,000 and 1:20,000 births.13 
PCD is a genetic disorder, causing abnormalities in 
the structure or function of the cilia, accumulating 
mucus in the lungs.13,14 Therefore, in these cases, 
bronchial dilation is secondary to mucus accumulation. 
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This criterion is useful for the diagnosis and was not 
observed in our case.
In the differential diagnosis, we must also include 
CF, which is a recessive autosomal disease15 resulting 
in thick viscous mucus that obstructs exocrine glands 
and bronchi lumens. In CF, obstruction and secondary 
infections are the causes of bronchiectasis,15 which was 
not found in our case.
The PS accounts for 0.15%-6.45% of all lung 
malformations and is characterized by non-functioning 
lung tissue that has no connection with the bronchial 
tree and receives its blood supply from the systemic 
circulation, via the descending thoracic aorta or 
the abdominal aorta.1 The absence of anomalous 
vascularization in this case excludes this hypothesis.
The congenital form of WCS is a cystic lung 
disease associated with a deficiency of cartilage in 
the bronchial tree. The diagnosis is made by excluding 
other common causes of bronchiectasis.16 The bilateral 
involvement of the lung and the association with 
other anomalies—particularly with congenital cardiac 
diseases—is often observed.16,17 The absence of both 
criteria does not favor this diagnosis for the described 
case.
CONCLUSION
This case is particularly interesting because it 
emphasizes the importance of the differential diagnosis 
of congenital cystic diseases of the lung, which are 
identified on gestational ultrasound. An accurate 
diagnosis is fundamental for prenatal counseling and 
better medical management to reduce mortality and 
to improve prognosis.
Procedures performed in studies involving human 
participants were in accordance with the ethical 
standards of the institutional and/or national research 
committee and with the 1964 Helsinki Declaration and 
its later amendments or comparable ethical standards. 
Informed consent was obtained from the participant 
of the study.
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